ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
August 15, 2024 05:00 ET
|
ANEW MEDICAL, INC.
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S. -based biotechnology company focused on developing cell and gene-based treatments for...
Nutraceutical Market Surges to USD 453.78 Billion by 2031, Propelled by 2.10% CAGR - Verified Market Research®
August 14, 2024 10:15 ET
|
Verified Market Research
Lewes, Delaware, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The Global Nutraceutical Market Size is projected to grow at a CAGR of 2.10% from 2024 to 2031, according to a new report published by Verified...
Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board
August 14, 2024 08:00 ET
|
MannKind
KENT KRESA TO RETIRE FROM MANNKIND’S BOARD OF DIRECTORS; STEVEN B. BINDER TO BE APPOINTED TO THE BOARD
[Latest] Global Pharmaceutical CRM Software Market Size/Share Worth USD 6,643.1 Million by 2033 at a 4.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 13, 2024 16:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical CRM Software Market Size, Trends and Insights By Deployment Type...
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 13, 2024 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 13, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
August 12, 2024 16:03 ET
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Life Science Tools and Reagents Market Report 2024, with Profiles of BD, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Merck, Promega, Qiagen, Revvity, Takara Bio and Thermo Fisher Scientific
August 12, 2024 05:10 ET
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Life Science Tools and Reagents: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for life science tools...
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
August 12, 2024 05:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
August 09, 2024 05:00 ET
|
ANEW MEDICAL, INC.
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides